Rombotis Spiro George 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Jul 3, 2023
Insider Transaction Report
Form 4
Rombotis Spiro George
DirectorPresident & C.E.O.
Transactions
- Award
Stock Option (right to buy)
2023-06-30+110,000→ 110,000 totalExercise: $0.59From: 2024-06-30Exp: 2033-06-30→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]The reporting person received an award of 110,000 options on June 30, 2023, which shall vest in full on June 30, 2026, provided, however, that if certain clinical milestones are achieved then such options shall vest in full earlier in connection with such achievement.